Market Size of Hyoscine Industry
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| CAGR | 4.00 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
| Market Concentration | Low |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Hyoscine Market Analysis
The hyoscine market is expected to register a CAGR of 4% during the forecast period.
The COVID-19 pandemic significantly impacted the hyoscine market in the initial phases as lockdowns and restrictions reduced the medicine's availability. However, the industry has been recovering strongly in the post-pandemic scenario. Over the past two years, a rise in product sales and increased travel by people promoted the market's growth.
Moreover, the increased incidence of motion sicknesses such as nausea and vomiting further led to the adoption of hyoscine medicines. Additionally, the market's growth is aided by increased research in the field of Hyoscine. For instance, an article published on April 2022 by BMC Journal showed that pre-treatment with intravenous hyoscine butyl-bromide (HBB) is a risk-free method for both the mother and the child in cesarean section patients undergoing spinal anesthesia to lower the risk of severe intraoperative bradycardia. Furthermore, the increase in travel worldwide is likely to boost the hyoscine market since motion sickness is mainly treated with hyoscine. For instance, as per the June 2022 report from UNWTO, the latest World Tourism Barometer showed an increase of 182% for international tourism in the first three months of 2022 compared to the previous year.
As per the above-mentioned factors, the hyoscine market is anticipated to grow during the forecast period. However, stringent regulation related to the manufacturing and marketing of hyoscine products may hamper the market to a certain extent.
Hyoscine Industry Segmentation
As per the scope of the report, Hyoscine is an effective medicine for motion sickness and is used to treat postoperative nausea, gastrointestinal spasm, and vomiting. This medicine belongs to the antimuscarinic family and works by blocking some acetylcholine effects within the nervous system.
The hyoscine market is segmented by Type (Hyoscine Butyl Bromide, Hyoscine Hydrobromide), Mode of Administration (Oral, Patches, Injections), and Geography (North America, Europe, Asia-Pacific, South America, and Middle East and Africa). The market report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers the value in USD million for the above segments.
| By Type | |
| Hyoscine Butylbromide | |
| Hyoscine Hydrobromide |
| By Mode of Administration | |
| Oral | |
| Patches | |
| Injections |
| Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Hyoscine Market Size Summary
The hyoscine market is poised for growth, driven by a resurgence in demand following the initial disruptions caused by the COVID-19 pandemic. The market is experiencing a recovery phase, with increased product sales and a rise in global travel contributing to its expansion. The prevalence of motion sickness, which hyoscine effectively treats, has further bolstered market adoption. Ongoing research and clinical studies, such as those published in reputable journals, are enhancing the understanding and application of hyoscine in various medical scenarios, including its use in cesarean sections and labor management. Despite the positive growth trajectory, the market faces challenges from stringent regulatory requirements governing the manufacturing and marketing of hyoscine products.
The oral segment of the hyoscine market is expected to dominate due to its ease of administration, availability, and cost-effectiveness compared to other forms like patches and injections. The growing patient pool and increasing travel activities are driving demand for oral hyoscine, supported by research highlighting its benefits in treating abdominal cramps and motion sickness. North America is anticipated to hold a significant share of the global market, supported by a robust healthcare infrastructure, increased healthcare expenditure, and ongoing research activities in the region. The competitive landscape is characterized by the presence of both international and local companies, with key players engaging in strategic initiatives to enhance product availability and market presence.
Hyoscine Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.2.1 Rise in Consumer Awareness Towards Hyoscine
-
1.2.2 Increase in Travelling
-
-
1.3 Market Restraints
-
1.3.1 Regulatory Framework
-
-
1.4 Porter's Five Force Analysis
-
1.4.1 Threat of New Entrants
-
1.4.2 Bargaining Power of Buyers/Consumers
-
1.4.3 Bargaining Power of Suppliers
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION (Market Size by Value - USD Million)
-
2.1 By Type
-
2.1.1 Hyoscine Butylbromide
-
2.1.2 Hyoscine Hydrobromide
-
-
2.2 By Mode of Administration
-
2.2.1 Oral
-
2.2.2 Patches
-
2.2.3 Injections
-
-
2.3 Geography
-
2.3.1 North America
-
2.3.1.1 United States
-
2.3.1.2 Canada
-
2.3.1.3 Mexico
-
-
2.3.2 Europe
-
2.3.2.1 Germany
-
2.3.2.2 United Kingdom
-
2.3.2.3 France
-
2.3.2.4 Italy
-
2.3.2.5 Spain
-
2.3.2.6 Rest of Europe
-
-
2.3.3 Asia Pacific
-
2.3.3.1 China
-
2.3.3.2 Japan
-
2.3.3.3 India
-
2.3.3.4 Australia
-
2.3.3.5 South Korea
-
2.3.3.6 Rest of Asia-Pacific
-
-
2.3.4 Middle East and Africa
-
2.3.4.1 GCC
-
2.3.4.2 South Africa
-
2.3.4.3 Rest of Middle East and Africa
-
-
2.3.5 South America
-
2.3.5.1 Brazil
-
2.3.5.2 Argentina
-
2.3.5.3 Rest of South America
-
-
-
Hyoscine Market Size FAQs
What is the current Hyoscine Market size?
The Hyoscine Market is projected to register a CAGR of 4% during the forecast period (2024-2029)
Who are the key players in Hyoscine Market?
Caleb Pharmaceuticals, Inc, Baxter International, Alchem International Pvt. Ltd, Perrigo and GSK plc are the major companies operating in the Hyoscine Market.
